Background

In 2020, an early-stage drug development company, was facing significant challenges in managing its business and financial operations. With a promising candidate for a novel therapeutic but limited in-house expertise in business leadership and administration, the company sought the assistance of specialized external services to streamline its operations and ensure sustainable growth. They partnered with CxORE to provide a fractional Chief Business Officer (CBO) responsible for all business and finance activities.

​

Initial Engagement

Upon engaging our fractional CBO, the company experienced immediate improvements in its business and financial management. The CBO’s responsibilities included:

• Financial Planning and Analysis: Developing comprehensive financial models, budgeting, and forecasting to support strategic decision-making.

• Funding and Investor Relations: Assisting in fundraising efforts, preparing investor presentations, investor negotiations, and maintaining strong communication with stakeholders.

• Business Strategy Development: Crafting and implementing strategic plans to align with the company’s long-term goals.

• Operational Oversight: Ensuring efficient and compliant operational processes.

​

Expanded Services

Two years into the partnership, in 2022, the company’s needs and growth necessitated additional support in various administrative and operational areas. Recognizing the need for a more holistic approach to their business management, the company opted to leverage the expertise of one of our fractional business teams. This team provided a suite of services encompassing:

• Contract Administration: Managing contracts with suppliers, partners, and service providers to ensure favorable terms and compliance.

• Administrative Processing: Streamlining administrative workflows to enhance efficiency and reduce overhead.

• Accounting: Offering comprehensive accounting services, including financial reporting, tax preparation, and audit support.

• Human Resources: Handling recruitment, onboarding, employee relations, and compliance with employment laws.

• Payroll: Managing payroll processing to ensure timely and accurate compensation for employees.

• Risk Mitigation: Compliance and governance oversight, insurance, and risk mitigation strategies and execution.

• Project Management: Providing support for miscellaneous projects to drive operational improvements and strategic initiatives.

​

Outcomes and Impact

The integration of our business team significantly enhanced the company’s operational capabilities. Key outcomes included:

• Improved Financial Health: With robust financial management and strategic guidance, the company successfully secured continued funding, ensuring the continued advancement of its drug development programs.

• Operational Efficiency: Streamlined administrative and operational processes, reduced overhead costs, and freed up internal resources to focus on core scientific activities.

• Regulatory Compliance: Comprehensive contract administration and insurance coordination minimized legal and financial risks.

• Employee Satisfaction: Enhanced HR and payroll services increased employee satisfaction and retention rates.

• Scalability: The scalable solutions provided by our team positioned the company for future growth, enabling them to handle increased operational demands as their pipeline progressed.

 

Conclusion

Our collaboration with the company exemplifies the value of integrated business and finance solutions for a wide array of early-to-mature organizations. By initially providing a fractional CBO and subsequently expanding our services to cover a wide range of administrative and operational functions, we helped the company navigate complex challenges, achieve financial stability, and lay the foundation for sustained growth. This case study highlights the importance of adaptable and comprehensive support in driving the success of emerging biotech companies.